IP Verse

Novartis Gene Therapies, Inc. et al. v. Genzyme Corporation et al. - IPR2023-01044

Explore the PTAB proceeding IPR2023-01044 filed by Novartis Gene Therapies, Inc. et al. against Genzyme Corporation et al. on Jun 30, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2023-01044
Filing Date
Jun 30, 2023
Petitioner
Novartis Gene Therapies, Inc. et al.
Respondent
Genzyme Corporation et al.
Status
Terminated-Settled
Respondent Application Number
15544498
Respondent Tech Center
1600
Respondent Patent Number
10429288
Institution Decision Date
Jan 9, 2024
Termination Date
Mar 4, 2024

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2023-01044.

TypeName
Petitioner CounselLivingstone, Johnet al
Respondent CounselAntons, Amandaet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.